CloudCath Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
2ndary - Private
- Investors
-
15
CloudCath General Information
Description
Developer of a remote monitoring platform and device designed to detect infectious disease progression for catheter-based treatments. The company's platform offers Internet of Things-based sensing hardware with a continuous monitoring system for early complication detection and treatment for patients who are on peritoneal dialysis, enabling healthcare providers to remotely monitor patients while they receive their home treatments.
Contact Information
Website
www.cloudcath.comCorporate Office
- 665 3rd Street
- Suite 250
- San Francisco, CA 94107
- United States
Corporate Office
- 665 3rd Street
- Suite 250
- San Francisco, CA 94107
- United States
CloudCath Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Early Stage VC (Series A) | 13-Feb-2020 | Completed | Generating Revenue | |||
| 6. Angel (individual) | 30-Jun-2019 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jun-2019 | Completed | Generating Revenue | |||
| 4. Angel (individual) | 24-Sep-2018 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 13-Mar-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue |
CloudCath Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-5 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | 1,191,667 | $0.000100 | $0.05 | $0.6 | $0.6 | 1x | $0.6 | 6.06% |
| Series A-2 | 250,000 | $0.000100 | $0.01 | $0.1 | $0.1 | 1x | $0.1 | 1.27% |
CloudCath Patents
CloudCath Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-192027-S | Fluid monitoring device | Active | 26-Jun-2019 | ||
| JP-2025118653-A | Fluid monitoring system, device, and method | Pending | 26-Jun-2019 | ||
| US-D984637-S1 | Measurement vessel | Active | 26-Jun-2019 | ||
| US-D903126-S1 | Monitoring device | Active | 26-Jun-2019 | ||
| AU-2020303702-A1 | Systems, devices, and methods for fluid monitoring | Inactive | 26-Jun-2019 | A61M1/28 |
CloudCath Signals
CloudCath Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Atacama Ventures | Venture Capital | Minority | ||
| Coconut Tree Investments | Corporation | Minority | ||
| Hanawa Group | Venture Capital | Minority | ||
| JTC Trust and Fiduciary Services | PE-Backed Company | Minority |
CloudCath FAQs
-
When was CloudCath founded?
CloudCath was founded in 2017.
-
Where is CloudCath headquartered?
CloudCath is headquartered in San Francisco, CA.
-
What is the size of CloudCath?
CloudCath has 22 total employees.
-
What industry is CloudCath in?
CloudCath’s primary industry is Monitoring Equipment.
-
Is CloudCath a private or public company?
CloudCath is a Private company.
-
What is CloudCath’s current revenue?
The current revenue for CloudCath is .
-
How much funding has CloudCath raised over time?
CloudCath has raised $12.1M.
-
Who are CloudCath’s investors?
, Atacama Ventures, Coconut Tree Investments, Hanawa Group, and JTC Trust and Fiduciary Services are 5 of 15 investors who have invested in CloudCath.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process